Digirad Corporation (NASDAQ:DRAD) is expected to pay $0.05 on Nov 28, 2016. The indicated annual dividend is $0.20. Shareholders owning the stock before Nov 15, 2016 will be eligible to receive the payout. Based on Digirad Corporation’s current price of $4.70, the dividend is 1.06%. This dividend’s record date is Nov 17, 2016 and the announcement date is Oct 28, 2016. The stock increased 1.08% or $0.05 on November 11, hitting $4.7. Digirad Corporation (NASDAQ:DRAD) has declined 14.23% since April 12, 2016 and is downtrending. It has underperformed by 19.22% the S&P500.
Digirad Corporation is a provider of diagnostic solutions. The company has a market cap of $93.49 million. The Company’s business is organized into two divisions: Diagnostic Services and Diagnostic Imaging. It has a 7.21 P/E ratio. The Firm provides in-office nuclear cardiology and ultrasound imaging services.
Insitutional Activity: The institutional sentiment increased to 1.35 in Q2 2016. Its up 0.53, from 0.82 in 2016Q1. The ratio improved, as 5 funds sold all Digirad Corporation shares owned while 15 reduced positions. 11 funds bought stakes while 16 increased positions. They now own 10.84 million shares or 2.53% less from 11.12 million shares in 2016Q1.
Blackrock Japan Limited holds 0% of its portfolio in Digirad Corporation (NASDAQ:DRAD) for 1,241 shares. The Texas-based Dimensional Fund Limited Partnership has invested 0% in Digirad Corporation (NASDAQ:DRAD). Deutsche Retail Bank Ag reported 158 shares or 0% of all its holdings. Hillsdale Investment Mgmt last reported 75,280 shares in the company. Thompson Davis And Co Inc reported 34,877 shares or 0.29% of all its holdings. Blackrock Fund Advsr has invested 0% of its portfolio in Digirad Corporation (NASDAQ:DRAD). California Pub Employees Retirement Sys owns 77,300 shares or 0% of their US portfolio. Moreover, Jbf Capital has 0.02% invested in Digirad Corporation (NASDAQ:DRAD) for 30,000 shares. Moreover, Blackrock Mgmt Ltd Co has 0% invested in Digirad Corporation (NASDAQ:DRAD) for 3,218 shares. Punch Inv Inc has 1.22M shares for 0.72% of their US portfolio. Amg Natl Natl Bank has 0.02% invested in the company for 50,842 shares. Moreover, Price T Rowe Associate Inc Md has 0% invested in Digirad Corporation (NASDAQ:DRAD) for 39,600 shares. Bridgeway Mngmt, a Texas-based fund reported 241,794 shares. The New York-based National Bank & Trust Of New York Mellon has invested 0% in Digirad Corporation (NASDAQ:DRAD). Ancora Advsr Limited Company last reported 0.19% of its portfolio in the stock.
Insider Transactions: Since May 27, 2016, the stock had 9 insider purchases, and 2 sales for $299,660 net activity. Another trade for 2,000 shares valued at $8,450 was made by Keyes Jeffry R. on Thursday, November 3. Another trade for 300 shares valued at $1,503 was bought by Eberwein Jeffrey E.. Molchan Matthew G. sold 5,833 shares worth $29,222. Lott Virgil sold $122,498 worth of stock or 23,333 shares.
More notable recent Digirad Corporation (NASDAQ:DRAD) news were published by: Marketwatch.com which released: “Digirad Corp. NASDAQ: DRAD” on December 21, 2009, also Globenewswire.com with their article: “Digirad Corporation Announces Agreement to Acquire DMS Health Technologies for …” published on October 14, 2015, Globenewswire.com published: “Digirad Corporation to Present at the Sidoti & Co. Fall 2016 Emerging Growth …” on October 12, 2016. More interesting news about Digirad Corporation (NASDAQ:DRAD) were released by: Globenewswire.com and their article: “Digirad Corporation to Release 2016 Third Quarter Financial Results on October …” published on June 08, 2016 as well as Nasdaq.com‘s news article titled: “Digirad Corporation (DRAD) Ex-Dividend Date Scheduled for August 15, 2016” with publication date: August 12, 2016.
DRAD Company Profile
Digirad Corporation, incorporated on January 2, 1997, is a well-known provider of diagnostic solutions. The Company’s business is organized into two divisions: Diagnostic Services and Diagnostic Imaging. The Firm provides in-office nuclear cardiology and ultrasound imaging services. The Firm also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Firm sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.